2000 Counterdrug Research and Development Blueprint Update
Appendix A:
Applicable Legislation
The following
highlights from applicable legislation summarize Counterdrug Technology
Assessment Center appropriations, functions, staff levels and roles.
- Conference
Report 104-863 of September 28, 1996 [To accompany H.R. 3610] Making
Omnibus Consolidated Appropriations For Fiscal Year 1997
(f) For programs,
projects or activities in the Treasury, Postal Service, and General
Appropriations Act, 1997, provided as follows, to be effective as
if it had been enacted into law as the regular appropriations Act:
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100-690; not to exceed
$8,000 for official reception and representation expenses; and for
participation in joint projects or in the provision of services on
matters of mutual interest with nonprofit, research, or public organizations
or agencies, with or without reimbursement; $35,838,000, of which
$19,000,000 shall remain available until expended, consisting of $1,000,000
for policy research and evaluation and $18,000,000 for the Counter-Drug
Technology Assessment Center for counternarcotics research and development
projects of which $1,000,000 shall be obligated for state conferences
on model state drug laws: Provided, That the $17,000,000 for the Counter-Drug
Technology Assessment Center shall be available for transfer to other
Federal departments or agencies: Provided further, That the Office
is authorized to accept, hold, administer, and utilize gifts, both
real and personal, for the purpose of aiding or facilitating the work
of the Office: Provided further, That not before January 31, 1997,
the Director of the Office of National Drug Control Policy shall transfer
all balances in the Special Forfeiture Fund established by section
6073 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. § 1509) to the
Treasury Forfeiture Fund (31 U.S.C. 9703(a))."
- P.L. 104-208
of September 30, 1996 - Making omnibus consolidated appropriations
for the fiscal year ending September 30, 1997, and for other purposes.
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100-690; ... $35,838,000,
of which $19,000,000 shall remain available until expended, consisting
of $1,000,000 for policy research and evaluation and $18,000,000 for
the Counter-Drug Technology Assessment Center for counternarcotics
research and development projects of which $1,000,000 shall be obligated
for state conferences on model state drug laws: Provided, That the
$17,000,000 for the Counter-Drug Technology Assessment Center shall
be available for transfer to other Federal departments or agencies:"
- Conference
Report 105-284 of September 29, 1997, [To accompany H.R. 2378] Making
Appropriations for the Treasury Department, The United States Postal
Service, The Executive Office Of The President, and certain independent
agencies, for the fiscal year ending September 30, 1998, and for
other purposes
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100– 690; not to
exceed $8,000 for official reception and representation expenses;
and for participation in joint projects or in the provision of services
on matters of mutual interest with nonprofit, research, or public
organizations or agencies, with or without reimbursement; $35,016,000,
of which $17,000,000 shall remain available until expended, consisting
of $1,000,000 for policy research and evaluation and $16,000,000 for
the Counterdrug Technology Assessment Center for counternarcotics
research and development projects: Provided, That the $16,000,000
for the Counterdrug Technology Assessment Center shall be available
for transfer to other Federal departments or agencies: Provided further,
That the Office is authorized to accept, hold, administer, and utilize
gifts, both real and personal, for the purpose of aiding or facilitating
the work of the Office: Provided further, That not before December
31, 1997, the Director of the Office of National Drug Control Policy
shall transfer all balances in the Special Forfeiture Fund established
by section 6073 of the Anti-drug Abuse Act of 1988 (21 U.S.C. section
1509) to the Treasury Forfeiture Fund (31 U.S.C. section 9703(a))."
"The conferees
provide $13,000,000 to the Counterdrug Technology Assessment Center
(CTAC) of the Office of National Drug Control Policy (ONDCP) to establish
a program for transferring technology directly to State and local
law enforcement agencies. Since its inception, CTAC has worked with
many law enforcement agencies and prosecutors to find technological
solutions to critical law enforcement problems, and many valuable
applications have been developed. The conferees direct that this new
funding be used to initiate a pilot program to transfer these technologies
directly to State and local law enforcement agencies who may otherwise
be unable to profit from the developments due to limited budgets or
a lack of technological expertise. The conferees direct CTAC to initiate
this program under the direction of the Chief Scientist, ONDCP, with
the advice of experts from State and local law enforcement, and in
cooperation with High Intensity Drug Trafficking Area (HIDTA) programs
to identify the technologies to be transferred and locations to be
served. The conferees expect that priority will be given to identifying
candidates for transfer in the currently designated HIDTAs, and expect
that CTAC and HIDTA will also weigh the ability and willingness of
potential recipients to share in the costs of new technology, either
through in-kind or direct contributions. The conferees also direct
the Chief Scientist to submit a report to the Committees on Appropriations
evaluating the performance of the program not later than 18 months
from the date of the first transfer, as well as a strategic plan for
countrywide deployment of technology. Additionally, the Chief Scientist
is directed to consult with the Committees on Appropriations prior
to the obligation of these funds to ensure that the money appropriated
is going toward providing State and local law enforcement agencies
access to counterdrug technology and not unreasonable administrative
or otherwise unintended purposes."
"The conferees
agree to provide $35,016,000 instead of $43,516,000 as proposed by
the House and $36,016,000 as proposed by the Senate. Of this amount,
the conferees have included $16,000,000 for the basic program of the
Counterdrug Technology Assessment Center, and $1,000,000 for policy
research and evaluation. The conference agreement separately funds
$13,000,000 for a new technology transfer program by the Counterdrug
Technology Assessment Center, as well as $1,200,000 for model state
drug law conferences, through the Violent Crime Reduction Trust Fund."
- P.L. 105-61
of October 10, 1997 - Treasury, Postal Service, and General Government
Appropriations of fiscal year ending September 30, 1998
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100-690; ...$35,016,000,
of which $17,000,000 shall remain available until expended, consisting
of $1,000,000 for research and evaluation and $16,000,000 for the
Counterdrug Technology Assessment Center for counternarcotics research
and development projects: Provided, That the $16,000,000 for the Counterdrug
Technology Assessment Center shall be available for transfer to other
Federal departments or agencies:"
"For activities
authorized by Public Law 103-322, to remain available until expended,
which shall be derived from the Violent Crime Reduction Trust Fund,
as follows: (1) As authorized by section 19001(e), $131,000,000; ...
of which $20,200,000 shall be available to the Office of National
Drug Control Policy, including $13,000,000 to the Counterdrug Technology
Assessment Center for a program to transfer technology to State and
local law enforcement agencies, ..."
- P.L. 105-85
of November 18, 1997 National Defense Authorization Act for fiscal
year 1998
"(a) Report Requirement.
— Not later than December 1st of each year, the Director of the
Office of National Drug Control Policy shall submit to Congress and
the President a report on the development and deployment of narcotics
detection technologies by Federal Agencies. Each such report shall
be prepared in consultation with the Secretary of Defense, the Secretary
of State, the Secretary of Transportation, and the Secretary of Treasury."
(b) Matters To
Be Included. — Each report under subsection (a) shall include-
(1) a description
of each project implemented by a Federal agency relating to the
development or deployment of narcotics detection technology;
(2) the agency responsible for each project described in paragraph
(1);
(3) the amount of funds obligated or expended to carry out each
project described in paragraph (1) during the fiscal year in which
the report is submitted or during any fiscal year preceding the
fiscal year in which the report is submitted;
(4) the
amount of funds estimated to be obligated or expended for each project
described in paragraph (1) during any fiscal year after the fiscal
year in which the report is submitted to Congress; and
(5) a detailed timeline for implementation of each project described
in paragraph (1).
- Conference
Report 105-760 of October 1, 1998 [to Accompany H.R. 4104] Appropriations
For The Treasury Department, The United States Postal Service, The
Executive Office Of The President, And Certain Independent Agencies,
For The Fiscal Year Ending September 30, 1999
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100-690; not to exceed
$8,000 for official reception and representation expenses; and for
participation in joint projects or in the provision of services on
matters of mutual interest with nonprofit, research, or public organizations
or agencies, with or without reimbursement, $48,042,000, of which
$30,100,000 shall remain available until expended, consisting of $1,100,000
for policy research and evaluation, and $16,000,000 for the counterdrug
Technology Assessment Center for counternarcotics research and development
projects, and $13,000,000 for the continued operation of the technology
transfer program: Provided, That the $16,000,000 for the Counterdrug
Technology Assessment Center shall be available for transfer to other
Federal departments or agencies: Provided further, That the Office
is authorized to accept, hold, administer, and utilize gifts, both
real and personal, public and private, without fiscal year limitation,
for the purpose of aiding or facilitating the work of the Office."
"The conferees
agree to provide $2,500,000 for ONDCP, instead of $14,000,000 as proposed
by the House and no funding as proposed by the Senate. $1,000,000
of this funding would cover the costs of continuing support for Model
State Drug Law Conferences, as proposed by the House. $13,000,000
proposed by the House for continued funding for the technology transfer
program run by the Counterdrug Technology Assessment Center will instead
be funded in the ONDCP Salaries and Expenses account, as proposed
by the Senate."
"The conferees
agree to provide $48,042,000 for the Office of National Drug Control
Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as
proposed by the House. This includes $13,000,000 to continue the technology
transfer pilot program managed by the Counterdrug Technology Assessment
Center (CTAC). It also includes $17,942,000 for ONDCP operations,
as proposed by the Senate, $16,000,000 for the basic CTAC program,
and $1,100,000 for policy research of which $100,000 is to be used
for evaluating the Drug-Free Communities Act, as proposed by the Senate.
The conferees agree to modify language governing the authority of
ONDCP to accept and use gifts. The conference agreement separately
funds $1,000,000 for Model State Drug Law Conferences through the
Violent Crime Reduction Trust Fund."
"The conferees
expect the multiagency research and development programs to be coordinated
by the Counterdrug Technology Assessment Center (CTAC) in order to
prevent duplication of effort and to assure that, whenever possible,
those efforts provide capabilities that transcend the need of any
single Federal agency. Prior to obligation of these funds, the conferees
expect to be notified by the chief scientist on how these funds will
be spent. The conferees also expect to receive periodic reports from
the chief scientist on the priority counterdrug enforcement research
and development requirements identified by the Center and on the status
of projects funded by CTAC."
- Conference
Report 105-789 of October 7, 1998 [To accompany H.R. 4104] Appropriations
For The Treasury Department, The United States Postal Service, The
Executive Office Of The President, and Certain Independent Agencies,
For the Fiscal Year Ending September 30, 1999
"The conferees
agree to provide $48,042,000 for the Office of National Drug Control
Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as
proposed by the House. This includes $13,000,000 to continue the technology
transfer pilot program managed by the Counterdrug Technology Assessment
Center (CTAC). It also includes $17,942,000 for ONDCP operations,
as proposed by the Senate, $16,000,000 for the basic CTAC program,
and $1,100,000 for policy research of which $100,000 is to be used
for evaluating the Drug-Free Communities Act, as proposed by the Senate.
The conferees agree to modify language governing the authority of
ONDCP to accept and use gifts. The conference agreement separately
funds $1,000,000 for Model State Drug Law Conferences through the
Violent Crime Reduction Trust Fund."
"The conferees
expect the multiagency research and development programs to be coordinated
by the Counterdrug Technology Assessment Center (CTAC) in order to
prevent duplication of effort and to assure that, whenever possible,
those efforts provide capabilities that transcend the need of any
single Federal agency. Prior to obligation of these funds, the conferees
expect to be notified by the chief scientist on how these funds will
be spent. The conferees also expect to receive periodic reports from
the chief scientist on the priority counterdrug enforcement research
and development requirements identified by the Center and on the status
of projects funded by CTAC. "
- Conference
Report 105-825 of October 19, 1998 [To accompany H.R. 4328] Making
Omnibus Consolidated and Emergency Supplemental Appropriations for
Fiscal Year 1999
"The conferees
agree to provide $48,042,000 for the Office of National Drug Control
Policy (ONDCP) as proposed by the Senate, instead of $36,442,000 as
proposed by the House. This includes $13,000,000 to continue the technology
transfer pilot program managed by the Counterdrug Technology Assessment
Center (CTAC). It also includes $17,942,000 for ONDCP operations,
as proposed by the Senate, $16,000,000 for the basic CTAC program,
and $1,100,000 for policy research of which $100,000 is to be used
for evaluating the Drug-Free Communities Act, as proposed by the Senate.
The conferees agree to modify language governing the authority of
ONDCP to accept and use gifts. The conference agreement separately
funds $1,000,000 for Model State Drug Law Conferences through the
Violent Crime Reduction Trust Fund."
"The conferees
expect the multiagency research and development programs to be coordinated
by the Counterdrug Technology Assessment Center (CTAC) in order to
prevent duplication of effort and to assure that, whenever possible,
those efforts provide capabilities that transcend the need of any
single Federal agency. Prior to obligation of these funds, the conferees
expect to be notified by the chief scientist on how these funds will
be spent. The conferees also expect to receive periodic reports from
the chief scientist on the priority counterdrug enforcement research
and development requirements identified by the Center and on the status
of projects funded by CTAC."
- P.L. 105-277
of October 21, 1998 [H.R. 4328] Omnibus Consolidated and Emergency
Supplemental Appropriations Act, 1999. Executive Office Appropriations
Act of 1999
"For necessary
expenses of the Office of National Drug Control Policy; for research
activities pursuant to title I of Public Law 100–690; not to
exceed $8,000 for official reception and representation expenses;
and for participation in joint projects or in the provision of services
on matters of mutual interest with nonprofit, research, or public
organizations or agencies, with or without reimbursement; $48,042,000,
of which $30,100,000 shall remain available until expended, consisting
of $1,100,000 for policy research and evaluation, and $16,000,000
for the Counterdrug Technology Assessment Center for counternarcotics
research and development projects, and $13,000,000 for the continued
operation of the technology transfer program: Provided, That
the $16,000,000 for the Counterdrug Technology Assessment Center shall
be available for transfer to other Federal departments or agencies:
Provided further, That the Office is authorized to accept,
hold, administer, and utilize gifts, both real and personal, public
and private, without fiscal year limitation, for the purpose of aiding
or facilitating the work of the Office."
- P.L. 105-277
of October 21, 1998 [H.R. 4328] (title VII of Division C) Office
of National Drug Control Policy Reauthorization Act of 1998
SEC. 708. COUNTER-DRUG
TECHNOLOGY ASSESSMENT CENTER.
(a) ESTABLISHMENT.—There
is established within the Office the Counter-Drug Technology Assessment
Center (referred to in this section as the ''Center''). The Center
shall operate under the authority of the Director of National Drug
Control Policy and shall serve as the central counter-drug technology
research and development organization of the United States Government.
(b) DIRECTOR OF
TECHNOLOGY.—There shall be at the head of the Center the Director
of Technology, who shall be appointed by the Director of National
Drug Control Policy from among individuals qualified and distinguished
in the area of science, medicine, engineering, or technology.
(c) ADDITIONAL
RESPONSIBILITIES OF THE DIRECTOR OF NATIONAL DRUG CONTROL POLICY.—
(1) IN GENERAL.—The
Director, acting through the Director of Technology shall—
(A) identify
and define the short-, medium-, and long-term scientific and technological
needs of Federal, State, and local drug supply reduction agencies,
including—
(i) advanced
surveillance, tracking, and radar imaging;
(ii) electronic
support measures;
(iii) communications;
(iv) data
fusion, advanced computer systems, and artificial intelligence;
and
(v) chemical,
biological, radiological (including neutron, electron, and graviton),
and other means of detection;
(B) identify
demand reduction basic and applied research needs and initiatives,
in consultation with affected National Drug Control Program agencies,
including—
(i) improving
treatment through neuroscientific advances;
(ii) improving
the transfer of biomedical research to the clinical setting;
and
(iii) in
consultation with the National Institute on Drug Abuse, and
through interagency agreements or grants, examining addiction
and rehabilitation research and the application of technology
to expanding the effectiveness or availability of drug treatment;
(C) make a
priority ranking of such needs identified in subparagraphs (A)
and (B) according to fiscal and technological feasibility, as
part of a National Counter-Drug Enforcement Research and Development
Program;
(D) oversee
and coordinate counter-drug technology initiatives with related
activities of other Federal civilian and military departments;
(E) provide
support to the development and implementation of the national
drug control performance measurement system; and
(F) pursuant
to the authority of the Director of National Drug Control Policy
under section 704, submit requests to Congress for the reprogramming
or transfer of funds appropriated for counter-drug technology
research and development.
(2) LIMITATION
ON AUTHORITY.—The authority granted to the Director under this
subsection shall not extend to the award of contracts, management
of individual projects, or other operational activities.
(d) ASSISTANCE
AND SUPPORT TO OFFICE OF NATIONAL DRUG CONTROL POLICY.—The
Secretary of Defense and the Secretary of Health and Human Services
shall, to the maximum extent practicable, render assistance and support
to the Office and to the Director in the conduct of counter-drug technology
assessment.
- Conference
Report 106-319 of September 14, 1999 [To accompany H.R. 2490] Making
Appropriations for The Treasury Department, The United States Postal
Service, The Executive Office Of The President, And Certain Independent
Agencies, For The Fiscal Year Ending September 30, 2000, And For
Other Purposes
"For necessary
expenses for the Counterdrug Technology Assessment Center for research
activities pursuant to the Office of National Drug Control Policy
Reauthorization Act of 1998 (title VII of Division C of Public Law
105–277), $29,250,000, which shall remain available until expended,
consisting of $16,000,000 for counternarcotics research and development
projects, and $13,250,000 for the continued operation of the technology
transfer program: Provided, That the $16,000,000 for counternarcotics
research and development projects shall be available for transfer
to other Federal departments or agencies."
"The conferees
agree to provide $29,250,000 instead of $31,100,000 as proposed by
the Senate. The House had proposed $29,250,000 in ONDCP's Salaries
and Expenses Appropriation. The conferees agree to establish this
new, separate appropriation account for the Counterdrug Technology
Assessment Center (CTAC) as authorized in Public Law 105-277 and proposed
by the Senate. It consists of $16,000,000 for the core research and
assessment activities of CTAC, as well as $13,250,000 for the counterdrug
technology transfer program."
- P.L. 106-58
of September 29, 1999 [H.R. 2490] Treasury And General Government
Appropriations Act, 2000
"For necessary
expenses for the Counterdrug Technology Assessment Center for research
activities pursuant to the Office of National Drug Control Policy
Reauthorization Act of 1998 (titleVII of Division C of Public Law
105-277), $29,250,000, which shall remain available until expended,
consisting of $16,000,000 for counternarcotics research and development
projects, and $13,250,000 for the continued operation of the technology
transfer program: Provided, That the $16,000,000 for counternarcotics
research and development projects shall be available for transfer
to other Federal departments or agencies."
- Conference
Report (H. Rept. 106-479) on H.R. 3194, Consolidated Appropriations
Act, 2000 (House of Representatives - November 17, 1999)
Division B,
Title II — Other Appropriations Matters
"Sec. 237. In
addition to amounts appropriated to the Office of National Drug Control
Policy, $3,000,000 is appropriated: Provided, That this amount shall
be made available by grant to the United States Olympic Committee
for its anti-doping program within 30 days of the enactment of this
Act."
- P.L. 106-113
of November 29, 1999: An act making consolidated appropriations
for the fiscal year ending September 30, 2000, and for other purposes.
Division B,
Appendix E, Title II — Other Appropriations Matters
"Sec. 237. In
addition to amounts appropriated to the Office of National Drug Control
Policy, $3,000,000 is appropriated: Provided, That this amount shall
be made available by grant to the United States Olympic Committee
for its anti doping program within 30 days of the enactment of this
Act."
